A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

NCT02035605 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Hemophilia B

Interventions

DRUG: ALN-AT3SC
DRUG: Sterile Normal Saline (0.9% NaCl)

Sponsor

Sanofi